Interaction of ropivacaine with cloned cardiac Kv4.3/KChIP2.2 complexes

Anesthesiology

Volumn 101, Issue 6, 2004, Pages 1347-1356

  Friederich, Patrick ^a   Solth, Anna ^a,b  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY OF HAMBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

POTASSIUM CHANNEL; ROPIVACAINE;

ANIMAL CELL; ARTICLE; CHEMICAL INTERACTION; CHO CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ELECTRIC CONDUCTIVITY; GENETIC TRANSFECTION; HEART; IC 50; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; PATCH CLAMP; POTASSIUM CHANNEL KCHIP 2.2; POTASSIUM CHANNEL KV 4.3; PRIORITY JOURNAL; STEREOSPECIFICITY;

EID: 9444282030     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-200412000-00015     Document Type: Article

References (37)

1. Valenzuela C, Delpon E, Franqueza L, Gay P, Snyders DJ, Tamargo J: Effects of ropivacaine on a potassium channel (hKv1.5) cloned from human ventricle. ANESTHESIOLOGY 1997; 86:718-28
2. Franqueza L, Longobardo M, Vicente J, Delpon E, Tamkun MM, Tamargo J, Snyders DJ, Valenzuela C: Molecular determinants of stereoselective bupivacaine block of hKv1.5 channels. Circ Res 1997; 81:1053-64
3. Lipka LJ, Jiang M, Tseng GN: Differential effects of bupivacaine on cardiac K channels: Role of channel inactivation and subunit composition in drug-channel interaction. J Cardiovasc Electrophysiol 1998; 9:727-42
4. Gonzalez T, Arias C, Caballero R, Moreno I, Delpon E, Tamargo J, Valenzuela C: Effects of levobupivacaine, ropivacaine and bupivacaine on HERG channels: Stereoselective bupivacaine block. Br J Pharmacol 2002; 137:1269-79
5. Friederich P, Solth A, Schillemeit S, Isbrandt D: Local anaesthetic sensitivities of cloned HERG channels from human heart: Comparison with HERG/MiRP1 and HERG/MiRP1T8A. Br J Anaesth 2004; 92:93-101
6. Kasten GW: Amide local anesthetic alterations of effective refractory period temporal dispersion: Relationship to ventricular arrhythmias. ANESTHESIOLOGY 1986; 65:61-6
7. Scott DB, Lee A, Fagan D, Bowler GM, Bloomfield P, Lundh R: Acute toxicity of ropivacaine compared with that of bupivacaine. Anesth Analg 1989; 69:563-9
8. Knudsen K, Beckman Suurkula M, Blomberg S, Sjovall J, Edvardsson N: Central nervous and cardiovascular effects of i.v. infusions of ropivacaine, bupivacaine and placebo in volunteers. Br J Anaesth 1997; 78:507-14
9. Dixon JE, Shi W, Wang HS, McDonald C, Yu H, Wymore RS, Cohen IS, McKinnon D: Role of the Kv4.3 K+ channel in ventricular muscle: A molecular correlate for the transient outward current. Circ Res 1996; 79:659-68
10. + channel diversity in the mammalian myocardium. J Physiol 2000; 525:285-98
11. Kaab S, Dixon J, Duc J, Ashen D, Nabauer M, Beuckelmann DJ, Steinbeck G, McKinnon D, Tomaselli GF: Molecular basis of transient outward potassium current downregulation in human heart failure: a decrease in Kv4.3 mRNA correlates with a reduction in current density. Circulation 1998; 98:1383-93
12. Nabauer M, Beuckelmann DJ, Erdmann E: Characteristics of transient outward current in human ventricular myocytes from patients with terminal heart failure. Circ Res 1993; 73:386-94
13. Jeck C, Pinto J, Boyden P: Transient outward currents in subendocardial Purkinje myocytes surviving in the infarcted heart. Circulation 1995; 92:465-73
14. Van Wagoner DR, Pond AL, McCarthy PM, Trimmer JS, Nerbonne JM: Outward K+ current densities and Kv1.5 expression are reduced in chronic human atrial fibrillation. Circ Res 1997; 80:772-81
15. Courtney KR, Kendig JJ: Bupivacaine is an effective potassium channel blocker in heart. Biochim Biophys Acta 1988; 939:163-6
16. Castle NA: Bupivacaine inhibits the transient outward K+ current but not the inward rectifier in rat ventricular myocytes. J Pharmacol Exp Ther 1990; 255:1038-46
17. Rosati B, Pan Z, Lypen S, Wang HS, Cohen I, Dixon JE, McKinnon D: Regulation of KChIP2 potassium channel beta subunit gene expression underlies the gradient of transient outward current in canine and human ventricle. J Physiol 2001; 533:119-25
18. Rosati B, Grau F, Rodriguez S, Li H, Nerbonne JM, McKinnon D: Concordant expression of KChIP2 mRNA, protein and transient outward current throughout the canine ventricle. J Physiol 2003; 548:815-22
19. Akar FG, Wu RC, Deschenes I, Armoundas AA, Piacentino V, Houser SR, Tomaselli GF: Phenotypic differences in the transient outward K+ current of human and canine ventricular myocytes: insights into the molecular composition of ventricular Ito. Am J Physiol Heart Circ Physiol 2004; 286:602-9
20. An WF, Bowlby MR, Betty M, Cao J, Ling HP, Mendoza G, Hinson JW, Mattsson KL, Strassle BW, Trimmer JS, Rhodes KJ: Modulation of A-type potassium channels by a family of calcium sensors. Nature 2000; 403:553-6
21. Guo W, Li H, Aimond F, Johns DC, Rhodes KJ, Trimmer T, Nerbonne JM: Role of heteromultimers in the generation of myocardial transient outward K+ currents. Circ Res 2002; 90:586-93
22. Bahring R, Dannenberg J, Peters HC, Leicher T, Pongs O, Isbrandt D: Conserved Kv4 N-terminal domain critical for effects of Kv channel-interacting protein 2.2 on channel expression and gating. J Biol Chem 2001; 276:23888-94
23. Beck EJ, Bowlby M, An WF, Rhodes KJ, Covarrubias M: Remodelling inactivation gating of Kv4 channels by KChIP1, a small-molecular-weight calcium-binding protein. J Physiol 2002; 538:691-706
24. Wang S, Patel SP, Qu Y, Hua P, Strauss HC, Morales MJ: Kinetic properties of Kv4.3 and their modulation by KChIP2b. Biochem Biophys Res Commun 2002; 295:223-9
25. Gebauer M, Isbrandt D, Sauter K, Callsen B, Nolting A, Pongs O, Bähring R N-type inactivation features of Kv4.2 channel gating. Biophys J 2004; 86:210-23
26. Kuo HC, Cheng CF, Clark RB, Lin JJ, Lin JL, Hoshijima M, Nguyen-Tran VT, Gu Y, Ikeda Y, Chu PH, Ross J, Giles WR, Chien KR: A defect in the Kv channel-interacting protein 2 (KChIP2) gene leads to a complete loss of I(to) and confers susceptibility to ventricular tachycardia. Cell 2001; 107:801-13
27. Sah R, Ramirez RJ, Backx PH: Modulation of Ca(2+) release in cardiac myocytes by changes in repolarization rate: role of phase-1 action potential repolarization in excitation-contraction coupling. Circ Res 2002; 90:165-73
28. Isbrandt D, Leicher T, Waldschutz R, Zhu X, Luhmann U, Michel U, Sauter K, Pongs O: Gene structures and expression profiles of three human KCND (Kv4) potassium channels mediating A-type currents I(TO) and I(SA). Genomics 2000; 64:144-54
29. Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ: Improved patchclamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch 1981; 391:85-100
30. Armstrong CM: Inactivation of the potassium conductance and related phenomena caused by quaternary ammonium ion injection in squid axons. J Gen Physiol 1969; 54:553-75
31. Zhou M, Morais-Cabral JH, Mann S, MacKinnon R: Potassium channel receptor site for the inactivation gate and quaternary amine inhibitors. Nature 2001; 411:657-61
32. Gonzalez T, Navarro-Polanco R, Arias C, Caballero R, Moreno I, Delpon E, Tamargo J, Tamkun MM, Valenzuela C: Assembly with the Kvbeta1.3 subunit modulates drug block of hKv1.5 channels. Mol Pharmacol 2002; 62:1456-63
33. Jerng HH, Shahidullah M, Covarrubias M: Inactivation gating of Kv4 potassium channels: Molecular interactions involving the inner vestibule of the pore. J Gen Physiol 1999; 113:641-60
34. Wettwer E, Himmel HM, Amos GJ, Li Q, Metzger F, Ravens U: Mechanism of block by tedisamil of transient outward current in human ventricular subepicardial myocytes. Br J Pharmacol 1998; 125:659-66
35. Sanchez-Chapula JA: Mechanism of transient outward K1 channel block by disopyramide. J Pharmacol Exp Ther 1999; 290:515-23
36. Feldman HS, Arthur GR, Covino BG: Comparative systemic toxicity of convulsant and supraconvulsant doses of intravenous ropivacaine, bupivacaine, and lidocaine in the conscious dog. Anesth Analg 1989; 69:794-801
37. Chang DH, Ladd LA, Copeland S, Iglesias MA, Plummer JL, Mather LE: Direct cardiac effects of intracoronary bupivacaine, levobupivacaine and ropivacaine in the sheep. Br J Pharmacol 2001; 132:649-58